You are here

Controlled Drugs National Group

  • Organisations we regulate

The group considers national controlled drugs governance in England.

It provides collaboration, consistency and assurance to government by:

  • sharing intelligence
  • highlighting good practice and areas of concern
  • reporting on the impact of controlled drugs arrangements

Membership of the national group

  • Care Quality Commission
  • Department of Health
  • General Medical Council
  • General Pharmaceutical Council
  • Health and Social Care Information Centre
  • Her Majesty's Inspectorate of Prisons for England and Wales
  • Medicines Advice (Medicines and Prescribing Centre) National Institute for Health and Care Excellence
  • Medicines and Healthcare products Regulatory Agency
  • Ministry of Defence
  • National Police Chiefs’ Council
  • NHS Counter Fraud Authority
  • NHS England (including Health and Justice Commissioning)
  • The Home Office
  • UK Anti-doping
  • Veterinary Medicines Directorate


Four sub-groups provide expert advice to the national group and issue newsletters. They cover these aspects of controlled drugs:

  • theft and fraud
  • monitoring prescribing
  • safe prescribing, dispensing and administration
  • policy and operational issues

Subgroup members are from the national group as well as invited specialists.

Sub-Group newsletters

These report on their findings and signpost guidance.

Latest newsletters

Controlled Drugs National Group newsletter: December 2018

Controlled Drugs National Group newsletter: August 2018

Controlled Drugs National Group newsletter: May 2018

Controlled Drugs National Group newsletter: volume 2, December 2017

Controlled Drugs National Group newsletter: volume 1, September 2017

Previous newsletters and guidance

See our earlier newsletters and guidance on safety incidents and checklists on the National Archives.

Last updated:
20 December 2018


Help us improve this page